within Pharmacolibrary.Drugs.ATC.B;

model B05AX03
  extends Pharmacokinetic.Models.PK_1C(
    weight         = 70,
    F              = 1,
    Cl             = 0.0,
    adminDuration  = 600,
    adminMass      = 250 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 5e-05,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>B05AX03</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Blood plasma is the liquid component of blood that serves as a medium for transporting nutrients, hormones, and waste products throughout the body. It is used therapeutically in plasma transfusions to treat patients with clotting disorders, trauma, burns, or in cases of massive blood loss. It is an approved and commonly used blood product in modern medicine.</p><h4>Pharmacokinetics</h4><p>Not applicable, as pharmacokinetic (PK) modeling in the classical sense (absorption, distribution, metabolism, excretion) is not standard for administered human plasma, which does not behave as a classical small molecule drug. Plasma is administered as a fluid replacement, and its behavior is governed by volume kinetics rather than traditional PK.</p><h4>References</h4><ol><li><p>Atkinson, HC, et al., &amp; Robson, R (2015). Pharmacokinetics and Bioavailability of a Fixed-Dose Combination of Ibuprofen and Paracetamol after Intravenous and Oral Administration. <i>Clinical drug investigation</i> 35(10) 625–632. DOI:<a href=&quot;https://doi.org/10.1007/s40261-015-0320-8&quot;>10.1007/s40261-015-0320-8</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/26334726/&quot;>https://pubmed.ncbi.nlm.nih.gov/26334726</a></p></li><li><p>Tang, Z, et al., &amp; Wang, S (2017). Liver, blood microdialysate and plasma pharmacokinetics of matrine following transdermal or intravenous administration. <i>Die Pharmazie</i> 72(3) 167–170. DOI:<a href=&quot;https://doi.org/10.1691/ph.2017.6101&quot;>10.1691/ph.2017.6101</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/29442052/&quot;>https://pubmed.ncbi.nlm.nih.gov/29442052</a></p></li><li><p>Rentsch, KM, et al., &amp; Hänseler, E (1997). Pharmacokinetics of N4-octadecyl-1-beta-D-arabinofuranosylcytosine in plasma and whole blood after intravenous and oral administration to mice. <i>The Journal of pharmacy and pharmacology</i> 49(11) 1076–1081. DOI:<a href=&quot;https://doi.org/10.1111/j.2042-7158.1997.tb06045.x&quot;>10.1111/j.2042-7158.1997.tb06045.x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/9401941/&quot;>https://pubmed.ncbi.nlm.nih.gov/9401941</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end B05AX03;
